Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Juan

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Gastroenterologia Y Hepatologia|March 18, 2005
[Chronic diarrhea with uncommon etiology]R Gil Borrás, O Juan Vidal, M I Talavera Encinas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 13, 2013
Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabineO Juan, J Vidal, R Gisbert, et al.
Journal of Molecular and Cellular Cardiology|December 16, 2015
LRP5 associates with specific subsets of macrophages: Molecular and functional effectsM Borrell-Pages, J C Romero, J Crespo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 24, 2005
Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growthMarta García-Ramírez, José Martínez-González, Josep O Juan-Babot, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 30, 2001
A randomized, crossover comparison of standard-dose versus low-dose lenograstim in the prophylaxis of post-chemotherapy neutropeniaO Juan, J M Campos, V Carañana, et al.
Revista Clinica Espanola|October 17, 1998
[Thrombopenic purpura caused by tetracyclines?]L A Navarro Seisdedos, O Juan Vidal, L de Paz Arias, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 19, 2020
Treatment strategy optimization for patients with non-small-cell lung cancer harboring EGFR mutation: a Delphi consensusD Isla, J de Castro, R García-Campelo, et al.
Medical Oncology (Northwood, London, England)|December 17, 2002
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropeniaJ Montalar, A Segura, C Bosch, et al.
Neoplasma|August 26, 2003
Weekly paclitaxel for advanced non-small cell lung cancer patients not suitable for platinum-based therapyO Juan, A Albert, T Villarroya, et al.
Acta Diabetologica|October 26, 2012
Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levelsL Nasarre, O Juan-Babot, P Gastelurrutia, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Gastroenterologia Y Hepatologia|March 18, 2005
[Chronic diarrhea with uncommon etiology]R Gil Borrás, O Juan Vidal, M I Talavera Encinas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 13, 2013
Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabineO Juan, J Vidal, R Gisbert, et al.
Journal of Molecular and Cellular Cardiology|December 16, 2015
LRP5 associates with specific subsets of macrophages: Molecular and functional effectsM Borrell-Pages, J C Romero, J Crespo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 24, 2005
Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growthMarta García-Ramírez, José Martínez-González, Josep O Juan-Babot, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 30, 2001
A randomized, crossover comparison of standard-dose versus low-dose lenograstim in the prophylaxis of post-chemotherapy neutropeniaO Juan, J M Campos, V Carañana, et al.
Revista Clinica Espanola|October 17, 1998
[Thrombopenic purpura caused by tetracyclines?]L A Navarro Seisdedos, O Juan Vidal, L de Paz Arias, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 19, 2020
Treatment strategy optimization for patients with non-small-cell lung cancer harboring EGFR mutation: a Delphi consensusD Isla, J de Castro, R García-Campelo, et al.
Medical Oncology (Northwood, London, England)|December 17, 2002
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropeniaJ Montalar, A Segura, C Bosch, et al.
Neoplasma|August 26, 2003
Weekly paclitaxel for advanced non-small cell lung cancer patients not suitable for platinum-based therapyO Juan, A Albert, T Villarroya, et al.
Acta Diabetologica|October 26, 2012
Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levelsL Nasarre, O Juan-Babot, P Gastelurrutia, et al.
Pageof 5